IN BRIEF: Oxford BioDynamics inks EpiSwitch kit deal with Agilent

Oxford BioDynamics PLC - biotechnology firm focused on discovery and development of epigenetic ...

Alliance News 31 March, 2021 | 9:18PM
Email Form Facebook Twitter LinkedIn RSS

Oxford BioDynamics PLC - biotechnology firm focused on discovery and development of epigenetic biomarkers - Signs supply and resale agreement with NYSE-listed Agilent Technologies, which operates in life sciences, diagnostics and applied chemical markets.

Under its terms, Agilent will supply a custom-made SurePrint G3 CGH Microarray for Oxford BioDynamics' EpiSwitch Explorer Array kit, which is for 3D genome profiling and biomarker discovery.

OBD meanwhile will have exclusive rights for the kit's supply and distribution.

Current stock price: 101.00 pence

Year-to-date change: up 22%

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Oxford BioDynamics PLC 52.00 GBX -1.89 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites
© Copyright 2021 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies       Modern Slavery Statement